Literature DB >> 4180576

Serum C'3 lytic system in patients with glomerulonephritis.

R E Spitzer, E H Vallota, J Forristal, E Sudora, A Stitzel, N C Davis, C D West.   

Abstract

The serums of patients with hypocomplementemic glomerulonephritis contain a substance that combines with a normal serum cofactor in the presence of magnesium ion to specifically cleave the third component of complement. This lysis of C'3 is 80 to 90 percent complete in 20 minutes at 37 degrees C and pH 7. Neither the nephritic factor nor its cofactor is identifiable with the complement system.

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4180576     DOI： 10.1126/science.164.3878.436

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  84 in total

1.  Membranoproliferative glomerulonephritis with partial lipodystrophy: discordant occurrence in identical twins.

Authors:  W Reichel; J Köbberling; H Fischbach; F Scheler
Journal:  Klin Wochenschr       Date:  1976-01-15

2.  Identification of nephritic factor as an immunoglobulin.

Authors:  D G Williams; A Bartlett; P Duffus
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

3.  C3 nephritic factor can be associated with membranous glomerulonephritis.

Authors:  Olivier Niel; Aymeric Dallocchio; Marie-Christine Thouret; Vincent Guigonis; Élisabeth Cassuto; Véronique Frémeaux-Bacchi; Étienne Bérard
Journal:  Pediatr Nephrol       Date:  2014-11-14       Impact factor: 3.714

Review 4.  Modern complement analysis.

Authors:  Michael Kirschfink; Tom E Mollnes
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

5.  C3 lytic factor in nephritis.

Authors:  E S Tucker
Journal:  Calif Med       Date:  1971-05

6.  Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).

Authors:  Rachael Watson; Emma Wearmouth; Amy-Claire McLoughlin; Arthur Jackson; Sophie Ward; Paula Bertram; Karim Bennaceur; Catriona E Barker; Isabel Y Pappworth; David Kavanagh; Susan M Lea; John P Atkinson; Timothy H J Goodship; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2014-08-21       Impact factor: 4.407

7.  C3 activator and hypocomplementaemia in a "healthy" woman.

Authors:  A Karstorp
Journal:  Br Med J       Date:  1976-02-28

8.  Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.

Authors:  J A Charlesworth; D G Williams; E Sherington; P J Lachmann; D K Peters
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

Review 9.  Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon.

Authors:  Y Levy; J George; E Yona; Y Shoenfeld
Journal:  Immunol Res       Date:  1998-08       Impact factor: 2.829

10.  Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis.

Authors:  E H Vallota; J Forristal; R E Spitzer; N C Davis; C D West
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.